Join the Hypoactive Sexual Desire Disorder group to help and get support from people like you.
Hypoactive Sexual Desire Disorder News
Related terms: HSDD, Female Sexual Dysfunction
Family Doctors Find It Tough To Talk Sex With Patients
WEDNESDAY, May 14, 2025 — Sex is an important part of people’s health, but family doctors find it tougher to counsel and treat patients for sexual health matters, a new study says. General pra...
Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
FRIDAY, Dec. 20, 2024 – Sexual minority women (SMW) report better sexual functioning in midlife than their heterosexual peers, according to a study published online Dec. 17 in Menopause. Laura A....
Non-heterosexual Women Report Better Sexual Functioning During Midlife
TUESDAY, Dec. 17, 2024 -- A woman’s sex drive often diminishes with age, particularly during perimenopause when issues like pain and vaginal discomfort arise. A new study, however, reveals that se...
Good Sex and Self Esteem Often Go Together, Study Finds
MONDAY, Sept. 30, 2024 – There's a strong link between self-esteem and good times between the sheets, a new study suggests. Folks ranking high in self-esteem also tended to rate their sex lives as...
Amag Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
WALTHAM, Mass. June 21, 2019 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that the U.S. Food and Drug Administration (FDA) has approved Vyleesi (bremelanotide injection), a melanocortin ...
FDA Orders Important Safety Labeling Changes for Addyi Regarding Alcohol Consumption
April 11, 2019 – The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise...
FDA Approves Addyi (flibanserin) for Hypoactive Sexual Desire Disorder in Premenopausal Women
August 18, 2015 - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to...